ENTERA BIO LTD. Research And Development Expense
ENTERA BIO LTD. (ENTX) reported Research And Development Expense of $1.26 million for the 3-month period ending 2021-06-30, per its 6-K filed 2021-08-16.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2021-08-16
- ENTERA BIO LTD. research and development expense for the quarter ending 2021-06-30 was $1.26M, a 37.44% decline year-over-year.
- ENTERA BIO LTD. research and development expense for the quarter ending 2020-06-30 was $2.01M, a 42.32% increase year-over-year.
- ENTERA BIO LTD. research and development expense for the quarter ending 2019-06-30 was $1.41M.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2021-06-30 | $1.26M 6-K · filed 2021-08-16 | $2.42M 6-K · filed 2021-08-16 | |
| 2020-12-31 | $6.40M 20-F · filed 2021-03-18 | ||
| 2020-06-30 | $2.01M 6-K · filed 2021-08-16 | $3.62M 6-K · filed 2021-08-16 | |
| 2019-12-31 | $7.20M 20-F · filed 2021-03-18 | ||
| 2019-06-30 | $1.41M 6-K · filed 2020-08-20 | $3.45M 6-K · filed 2020-08-20 | |
| 2018-12-31 | $8.52M 20-F · filed 2021-03-18 | ||
| 2017-12-31 | $2.77M 20-F · filed 2020-03-26 | ||
| 2016-12-31 | $2.65M 20-F · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |